These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 29489494)

  • 41. Cognitive function in older adults with major depression: Effects of mineralocorticoid receptor stimulation.
    Otte C; Wingenfeld K; Kuehl LK; Richter S; Regen F; Piber D; Hinkelmann K
    J Psychiatr Res; 2015 Oct; 69():120-5. PubMed ID: 26343603
    [TBL] [Abstract][Full Text] [Related]  

  • 42. An open-label pilot study of St. John's wort in juvenile depression.
    Findling RL; McNamara NK; O'Riordan MA; Reed MD; Demeter CA; Branicky LA; Blumer JL
    J Am Acad Child Adolesc Psychiatry; 2003 Aug; 42(8):908-14. PubMed ID: 12874492
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A randomized, double-blind, placebo-controlled phase 2 study of the augmentation of a nicotinic acetylcholine receptor partial agonist in depression: is there a relationship to leptin levels?
    Fava M; Ramey T; Pickering E; Kinrys G; Boyer S; Altstiel L
    J Clin Psychopharmacol; 2015 Feb; 35(1):51-6. PubMed ID: 25422883
    [TBL] [Abstract][Full Text] [Related]  

  • 44. LI 160, an extract of St. John's wort, versus amitriptyline in mildly to moderately depressed outpatients--a controlled 6-week clinical trial.
    Wheatley D
    Pharmacopsychiatry; 1997 Sep; 30 Suppl 2():77-80. PubMed ID: 9342764
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Hypericum extract WS ® 5570 for depression--an overview.
    Gastpar M
    Int J Psychiatry Clin Pract; 2013 Nov; 17 Suppl 1():1-7. PubMed ID: 23808616
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A randomized, double-blind, placebo-controlled trial of desvenlafaxine succinate in the treatment of major depressive disorder.
    Septien-Velez L; Pitrosky B; Padmanabhan SK; Germain JM; Tourian KA
    Int Clin Psychopharmacol; 2007 Nov; 22(6):338-47. PubMed ID: 17917552
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Mechanism of action of St John's wort in depression : what is known?
    Butterweck V
    CNS Drugs; 2003; 17(8):539-62. PubMed ID: 12775192
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effects of Hypericum perforatum (St. John's wort) on hot flashes and quality of life in perimenopausal women: a randomized pilot trial.
    Al-Akoum M; Maunsell E; Verreault R; Provencher L; Otis H; Dodin S
    Menopause; 2009; 16(2):307-14. PubMed ID: 19194342
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Antidepressant Effects of a Single Dose of Ayahuasca in Patients With Recurrent Depression: A SPECT Study.
    Sanches RF; de Lima Osório F; Dos Santos RG; Macedo LR; Maia-de-Oliveira JP; Wichert-Ana L; de Araujo DB; Riba J; Crippa JA; Hallak JE
    J Clin Psychopharmacol; 2016 Feb; 36(1):77-81. PubMed ID: 26650973
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A double-blind, placebo-controlled treatment trial of citalopram for major depressive disorder in older patients with heart failure: the relevance of the placebo effect and psychological symptoms.
    Fraguas R; da Silva Telles RM; Alves TC; Andrei AM; Rays J; Iosifescu DV; Wajngarten M
    Contemp Clin Trials; 2009 May; 30(3):205-11. PubMed ID: 19470312
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Hypericum extract LI 160 and fluoxetine in mild to moderate depression: a randomized, placebo-controlled multi-center study in outpatients.
    Bjerkenstedt L; Edman GV; Alken RG; Mannel M
    Eur Arch Psychiatry Clin Neurosci; 2005 Feb; 255(1):40-7. PubMed ID: 15538592
    [TBL] [Abstract][Full Text] [Related]  

  • 52. St. John's wort in mild to moderate depression: the relevance of hyperforin for the clinical efficacy.
    Laakmann G; Schüle C; Baghai T; Kieser M
    Pharmacopsychiatry; 1998 Jun; 31 Suppl 1():54-9. PubMed ID: 9684948
    [TBL] [Abstract][Full Text] [Related]  

  • 53. St John's wort for depression: meta-analysis of randomised controlled trials.
    Linde K; Berner M; Egger M; Mulrow C
    Br J Psychiatry; 2005 Feb; 186():99-107. PubMed ID: 15684231
    [TBL] [Abstract][Full Text] [Related]  

  • 54. BDNF, interleukin-6, and salivary cortisol levels in depressed patients treated with desvenlafaxine.
    Ninan PT; Shelton RC; Bao W; Guico-Pabia CJ
    Prog Neuropsychopharmacol Biol Psychiatry; 2014 Jan; 48():86-91. PubMed ID: 24096053
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effects of mineralocorticoid receptor blockade on empathy in patients with major depressive disorder.
    Wingenfeld K; Kuehl LK; Dziobek I; Roepke S; Otte C; Hinkelmann K
    Cogn Affect Behav Neurosci; 2016 Oct; 16(5):902-10. PubMed ID: 27383377
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Adjunct Therapy With Glycyrrhiza Glabra Rapidly Improves Outcome in Depression-A Pilot Study to Support 11-Beta-Hydroxysteroid Dehydrogenase Type 2 Inhibition as a New Target.
    Murck H; Lehr L; Hahn J; Braunisch MC; Jezova D; Zavorotnyy M
    Front Psychiatry; 2020; 11():605949. PubMed ID: 33362613
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The effect of Hypericum perforatum on postmenopausal symptoms and depression: A randomized controlled trial.
    Eatemadnia A; Ansari S; Abedi P; Najar S
    Complement Ther Med; 2019 Aug; 45():109-113. PubMed ID: 31331546
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Role in depression of a multi-fractionated versus a conventional Hypericum perforatum extract.
    Di Pierro F; Risso P; Settembre R
    Panminerva Med; 2018 Dec; 60(4):156-160. PubMed ID: 29991209
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Subchronic treatment with St John's wort produces a positive shift in emotional processing in healthy volunteers.
    Warren MB; Cowen PJ; Harmer CJ
    J Psychopharmacol; 2019 Feb; 33(2):194-201. PubMed ID: 30484733
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Adaptogens on Depression-Related Outcomes: A Systematic Integrative Review and Rationale of Synergism with Physical Activity.
    Sánchez IA; Cuchimba JA; Pineda MC; Argüello YP; Kočí J; Kreider RB; Petro JL; Bonilla DA
    Int J Environ Res Public Health; 2023 Mar; 20(7):. PubMed ID: 37047914
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.